Regrese osteolytického ložiska u pacienta s mnohočetným myelomem léčeného klodronátem po úspěšné terapii režimem s bortezomibem

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Title in English Regression of an Osteolytic Lesion in Patient with Multiple Myeloma Treated with Clodronate after a Successful Therapy with Bortezomib-based Regimen
Authors

SZTURZ Petr JAKUBCOVÁ R. ADAM Zdeněk KLINCOVÁ Mária KREJČÍ Marta POUR Luděk ZAHRADOVÁ Lenka HÁJEK Roman MAYER Jiří

Year of publication 2011
Type Article in Periodical
Magazine / Source Klinická onkologie
MU Faculty or unit

Faculty of Medicine

Citation
Field Oncology and hematology
Keywords ;multiple myeloma; bortezomib; bisphosphonates; osteolysis; osteogenesis; radiography
Description Osteolytic lesions are a common manifestation of multiple myeloma, though their healing is rare in these patients. Generally, during a complete remission, lesions only stop progressing; radiologically evident recalcification is exceptional. Herein we report a case of a male patient born in 1941 and diagnosed in 2005 with IgA multiple myeloma presenting with multiple osteolytic bone lesion. A complete remission of the disease after an administration of bortezomib (Velcade) based regimen in long-term clodronate (Bonefos) treated patient with relapsed multiple myeloma is radiographically apparent by clear healing signs of the osteolytic bone lesion.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.